| 靶点: |
IC50: 2.0 nM (MTP) |
| 体内研究: |
CP-346086 (1-100 mg/kg; oral gavage once daily for 2 weeks) reduces plasma total, VLDL, and LDL cholesterol and triglycerides in mice. CP-346086 (25 mg/kg; a single p.o.) results in an almost complete inhibition of Tyloxapol-induced triglyceride accumulation in fasted rats. CP-346086 (0.1-10 mg/kg; a single p.o.) reduces acute plasma triglyceride in mice. |
| 参考文献: |
1. Chandler CE, et, al. CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans. J Lipid Res. 2003 Oct;44(10):1887-901. |
| 溶解性: |
DMSO: >20mg/mL |
| 保存条件: |
2-8°C |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.099 ml |
10.494 ml |
20.988 ml |
| 5 mM |
0.42 ml |
2.099 ml |
4.198 ml |
| 10 mM |
0.21 ml |
1.049 ml |
2.099 ml |
| 50 mM |
0.042 ml |
0.21 ml |
0.42 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |